These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37371847)

  • 1. Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease.
    Kwak KA; Lee SP; Yang JY; Park YS
    Stem Cells Int; 2018; 2018():6392986. PubMed ID: 29686714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease Treatments.
    Sharma A; Kumar Y
    J Alzheimers Dis Rep; 2019 Nov; 3(1):279-297. PubMed ID: 31867567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets.
    Adamu A; Li S; Gao F; Xue G
    Front Aging Neurosci; 2024; 16():1347987. PubMed ID: 38681666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Tau Targeting Biomimetics Nano Formulations: Novel Approach for Targeting Alzheimer's Diseases.
    Singh A; Maheshwari S; Yadav JP; Varshney AP; Singh S; Prajapati BG
    Cent Nerv Syst Agents Med Chem; 2024; 24(3):294-303. PubMed ID: 38646682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromodulation by nanozymes and ultrasound during Alzheimer's disease management.
    Karthika V; Badrinathan Sridharan ; Nam JW; Kim D; Gyun Lim H
    J Nanobiotechnology; 2024 Mar; 22(1):139. PubMed ID: 38555420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer's Disease Management.
    Dighe S; Jog S; Momin M; Sawarkar S; Omri A
    Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanopharmacology as a new approach to treat neuroinflammatory disorders.
    Menéndez SG; Manucha W
    Transl Neurosci; 2023 Jan; 14(1):20220328. PubMed ID: 38152092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Nanocarriers for Alzheimer's Disease: Befriending the Barriers.
    Ansari MA; Tripathi T; Venkidasamy B; Monziani A; Rajakumar G; Alomary MN; Alyahya SA; Onimus O; D'souza N; Barkat MA; Al-Suhaimi EA; Samynathan R; Thiruvengadam M
    Mol Neurobiol; 2024 May; 61(5):3042-3089. PubMed ID: 37966683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles loaded with natural medicines for the treatment of Alzheimer's disease.
    Liu N; Ruan J; Li H; Fu J
    Front Neurosci; 2023; 17():1112435. PubMed ID: 37877008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
    Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine in the Management of Alzheimer's Disease: State-of-the-Art.
    Mir Najib Ullah SN; Afzal O; Altamimi ASA; Ather H; Sultana S; Almalki WH; Bharti P; Sahoo A; Dwivedi K; Khan G; Sultana S; Alzahrani A; Rahman M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.
    Wilson B; Geetha KM
    J Control Release; 2020 Sep; 325():25-37. PubMed ID: 32473177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicine: A Promising Way to Manage Alzheimer's Disease.
    Khan NH; Mir M; Ngowi EE; Zafar U; Khakwani MMAK; Khattak S; Zhai YK; Jiang ES; Zheng M; Duan SF; Wei JS; Wu DD; Ji XY
    Front Bioeng Biotechnol; 2021; 9():630055. PubMed ID: 33996777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease.
    Ahmad MZ; Ahmad J; Amin S; Rahman M; Anwar M; Mallick N; Ahmad FJ; Rahman Z; Kamal MA; Akhter S
    CNS Neurol Disord Drug Targets; 2014; 13(8):1315-24. PubMed ID: 25345516
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.